BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15963951)

  • 1. Microarray analysis of tumour antigen expression in presentation acute myeloid leukaemia.
    Guinn BA; Gilkes AF; Woodward E; Westwood NB; Mufti GJ; Linch D; Burnett AK; Mills KI
    Biochem Biophys Res Commun; 2005 Aug; 333(3):703-13. PubMed ID: 15963951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.
    Guinn BA; Bland EA; Lodi U; Liggins AP; Tobal K; Petters S; Wells JW; Banham AH; Mufti GJ
    Biochem Biophys Res Commun; 2005 Oct; 335(4):1293-304. PubMed ID: 16112646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent expression of HAGE in presentation chronic myeloid leukaemias.
    Adams SP; Sahota SS; Mijovic A; Czepulkowski B; Padua RA; Mufti GJ; Guinn BA
    Leukemia; 2002 Nov; 16(11):2238-42. PubMed ID: 12399967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine expression profiling of microarray gene signatures in acute leukaemia by real-time PCR of human bone marrow.
    Sakhinia E; Faranghpour M; Liu Yin JA; Brady G; Hoyland JA; Byers RJ
    Br J Haematol; 2005 Jul; 130(2):233-48. PubMed ID: 16029452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia.
    Strathdee G; Sim A; Soutar R; Holyoake TL; Brown R
    Carcinogenesis; 2007 Feb; 28(2):299-309. PubMed ID: 16861263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential target antigens for immunotherapy in human pancreatic cancer.
    Schmitz-Winnenthal FH; Galindo-Escobedo LV; Rimoldi D; Geng W; Romero P; Koch M; Weitz J; Krempien R; Niethammer AG; Beckhove P; Buchler MW; Z'graggen K
    Cancer Lett; 2007 Jul; 252(2):290-8. PubMed ID: 17320278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4 expressed by chemoresistant, as well as untreated, myeloid leukaemia cells can be targeted with ligands to induce apoptosis.
    Laurent S; Palmisano GL; Martelli AM; Kato T; Tazzari PL; Pierri I; Clavio M; Dozin B; Balbi G; Megna M; Morabito A; Lamparelli T; Bacigalupo A; Gobbi M; Pistillo MP
    Br J Haematol; 2007 Feb; 136(4):597-608. PubMed ID: 17367412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
    Neudenberger J; Hotfilder M; Rosemann A; Langebrake C; Reinhardt D; Pieters R; Schrauder A; Schrappe M; Röttgers S; Harbott J; Vormoor J
    Br J Haematol; 2006 May; 133(3):337-44. PubMed ID: 16643437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of acute myeloid leukaemia associated microRNA expression patterns.
    Isken F; Steffen B; Merk S; Dugas M; Markus B; Tidow N; Zühlsdorf M; Illmer T; Thiede C; Berdel WE; Serve H; Müller-Tidow C
    Br J Haematol; 2008 Jan; 140(2):153-61. PubMed ID: 18173753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia.
    Trnková Z; Bedrlíková R; Marková J; Michalová K; Stöckbauer P; Schwarz J
    Neoplasma; 2007; 54(5):383-90. PubMed ID: 17688368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis.
    Yokoe T; Tanaka F; Mimori K; Inoue H; Ohmachi T; Kusunoki M; Mori M
    Cancer Res; 2008 Feb; 68(4):1074-82. PubMed ID: 18281482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: implications for immunotherapy in South African populations.
    Dakshinamurthy AG; Ramesar R; Goldberg P; Blackburn JM
    Biotechnol J; 2008 Nov; 3(11):1417-23. PubMed ID: 18956367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia.
    Ortmann CA; Eisele L; Nückel H; Klein-Hitpass L; Führer A; Dührsen U; Zeschnigk M
    Ann Hematol; 2008 Oct; 87(10):809-18. PubMed ID: 18587578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the target receptor CD33 in CD34+/CD38-/CD123+ AML stem cells.
    Hauswirth AW; Florian S; Printz D; Sotlar K; Krauth MT; Fritsch G; Schernthaner GH; Wacheck V; Selzer E; Sperr WR; Valent P
    Eur J Clin Invest; 2007 Jan; 37(1):73-82. PubMed ID: 17181570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemia.
    Spanaki A; Perdikogianni C; Linardakis E; Kalmanti M
    Leuk Res; 2007 May; 31(5):639-42. PubMed ID: 16860864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
    Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
    Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common alterations in gene expression and increased proliferation in recurrent acute myeloid leukemia.
    Staber PB; Linkesch W; Zauner D; Beham-Schmid C; Guelly C; Schauer S; Sill H; Hoefler G
    Oncogene; 2004 Jan; 23(4):894-904. PubMed ID: 14749762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia.
    Rodrigues PC; Oliveira SN; Viana MB; Matsuda EI; Nowill AE; Brandalise SR; Yunes JA
    Pediatr Blood Cancer; 2007 Aug; 49(2):133-8. PubMed ID: 16883592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications.
    van de Loosdrecht AA; van den Ancker W; Houtenbos I; Ossenkoppele GJ; Westers TM
    Handb Exp Pharmacol; 2009; (188):319-48. PubMed ID: 19031033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.